Kura Oncology's total assets for Q1 2025 were $743.76M, a decrease of -2.16% from the previous quarter. KURA total liabilities were $379.36M for the fiscal quarter, a 9.48% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.